89bio, Inc. (ETNB) Misses Q4 EPS by 27c

89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($1.02), $0.27 worse than the analyst estimate of ($0.75).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• Meta to invest $13 billion CAD in first Canadian data center
• SRX Global reports $60M net asset value after EMJX acquisition
• Old Dominion Freight Line (ODFL) call put ratio 1 call to 3.1 puts as share price up 1.4%